These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2719894)

  • 1. Cardiovascular (ECG and systolic time intervals) and anticholinergic effects of repeated doses of femoxetine--a comparison with amitriptyline and placebo in healthy men.
    Warrington SJ; Turner P; Skrumsager BK
    Br J Clin Pharmacol; 1989 Mar; 27(3):343-51. PubMed ID: 2719894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic and blood pressure effects of mianserin, amitriptyline and placebo.
    Kopera H
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):29S-34S. PubMed ID: 341941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a new antiarrhythmic agent, flecainide acetate, on systolic time intervals.
    Muhiddin KA; Shaw E; Blackett A; Patel L; Turner P
    Eur J Clin Pharmacol; 1983; 25(1):13-8. PubMed ID: 6617715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Femoxetine and amitriptyline in general practice: a randomized double-blind group comparison.
    Skrumsager BK; Jeppesen K
    Pharmacopsychiatry; 1986 Sep; 19(5):368-77. PubMed ID: 3774871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effect of amitriptyline in standard and sustained-release formulations on cardiac systolic time intervals.
    Pickup AJ; Bojanowski LM; Dawling S; Dinsdale J; Gosling RG
    J Cardiovasc Pharmacol; 1982; 4(4):575-83. PubMed ID: 6181331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and subacute effects on psychomotor performance of femoxetine alone and with alcohol.
    Strömberg C; Mattila MJ
    Eur J Clin Pharmacol; 1985; 28(6):641-7. PubMed ID: 4065188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and psychomotor effects of repeated doses of paroxetine: a comparison with amitriptyline and placebo in healthy men.
    Warrington SJ; Dana-Haeri J; Sinclair AJ
    Acta Psychiatr Scand Suppl; 1989; 350():42-4. PubMed ID: 2530786
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of some effects of paroxetine with amitriptyline on the cardiovascular system in animals.
    Hamilton TC; Norton J; Poyser RH; Thormählen D
    Arzneimittelforschung; 1986 Mar; 36(3):460-3. PubMed ID: 2939838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled double-blind study of femoxetine and amitriptyline in patients with endogenous depression.
    Reebye PN; Yiptong C; Samsoon J; Schulsinger F; Fabricius J
    Pharmacopsychiatria; 1982 Sep; 15(5):164-9. PubMed ID: 6757983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers.
    Penttilä J; Syvälahti E; Hinkka S; Kuusela T; Scheinin H
    Psychopharmacology (Berl); 2001 Apr; 154(4):343-9. PubMed ID: 11349386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological and haemodynamic changes with trazodone, amitriptyline and placebo in depressed out-patients.
    Van de Merwe TJ; Silverstone T; Ankier SI
    Curr Med Res Opin; 1984; 9(5):339-52. PubMed ID: 6529913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of amitriptyline, mianserin, zimelidine and nomifensine in depressed patients.
    Burgess CD; Montgomery S; Wadsworth J; Turner P
    Postgrad Med J; 1979 Oct; 55(648):704-8. PubMed ID: 537956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of single doses of the antidepressants amitriptyline and lofepramine in healthy subjects.
    Stern H; Konetschny J; Herrmann L; Säwe U; Belz GG
    Pharmacopsychiatry; 1985 Jul; 18(4):272-7. PubMed ID: 3895254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Femoxetine in the treatment of obese patients in general practice. A randomized group comparative study with placebo.
    Bitsch M; Skrumsager BK
    Int J Obes; 1987; 11(2):183-90. PubMed ID: 3301710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Femoxetine in the prophylaxis of migraine--a randomised comparison with placebo.
    Zeeberg I; Orholm M; Nielsen JD; Honore PL; Larsen JJ
    Acta Neurol Scand; 1981 Dec; 64(6):452-9. PubMed ID: 6753446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of accessory symptoms in narcolepsy: a double-blind cross-over study of a selective serotonin re-uptake inhibitor (femoxetine) versus placebo.
    Schrader H; Kayed K; Bendixen Markset AC; Treidene HE
    Acta Neurol Scand; 1986 Oct; 74(4):297-303. PubMed ID: 3544654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. So-called "tension headache"--the response to a 5-HT uptake inhibitor: femoxetine.
    Sjaastad O
    Cephalalgia; 1983 Mar; 3(1):53-60. PubMed ID: 6850822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of mianserin and amitriptyline in healthy volunteers.
    Wester HA; Siegers CP
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):513-7. PubMed ID: 7228446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of fluoxetine and amitriptyline on cardiac function.
    Upward JW; Edwards JG; Goldie A; Waller DG
    Br J Clin Pharmacol; 1988 Oct; 26(4):399-402. PubMed ID: 3263876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amitriptyline and clomipramine in the isolated, perfused rabbit heart.
    Nielsen-Kudsk F; Quist S
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):263-9. PubMed ID: 7368944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.